Team
The JBL Group consultants bring a variety of impressive credentials and experiences gained in the pharmaceutical and related health care sectors, and provide an in-depth understanding of complex issues at both the Federal and Provincial levels across Canada.
Moreover, our consultants work as an integrated team, not only as individuals, to deliver the results our clients expect. Learn more
Back to team
Bernard Lachapelle
President
President
HIGHLIGHTS
Extensive senior career experience in Canadian pharmaceutical industry
Expertise in:
- Government Affairs
- Health Policy Development
- Marketing
- Pricing
- Corporate Communications
- International Affairs
Member of the Pharmaceutical Executive Editorial Advisory Board
Based in Montreal
Professional experience
Bernard Lachapelle is the President of The JBL Group. Before establishing the company in 2000, Bernard held Senior Executive positions with Hoechst Marion Roussel and Eli Lilly Canada. He has over 30 years of experience in Government Affairs, Pricing and Reimbursement, Managed Care, Health Policy Development and Corporate Communications as well as Marketing, Pricing and Tendering, and Human Resources.
A graduate of the Laval University School of Pharmacy, Bernard has been involved in the political process for many years and continues to serve the community in several capacities. A past Chairman of the Ballets Jazz de Montreal, Bernard is currently Chairman of the Board of Innovation Life Canada, the organization that oversees the prestigious Prix Galien in this country, and a member of the Boards of Directors of IRICoR (Centre for the commercialization of research of the Institute for Research in Immunology and Cancer) and the Quebec Cancer Foundation.
A graduate of the Laval University School of Pharmacy, Bernard has been involved in the political process for many years and continues to serve the community in several capacities. A past Chairman of the Ballets Jazz de Montreal, Bernard is currently Chairman of the Board of Innovation Life Canada, the organization that oversees the prestigious Prix Galien in this country, and a member of the Boards of Directors of IRICoR (Centre for the commercialization of research of the Institute for Research in Immunology and Cancer) and the Quebec Cancer Foundation.